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1. Introduction  
Drug resistance is one of our biggest problems in terms of cancer therapy. 
Chemotherapeutic drug therapy in cancer is seriously hampered by severe toxicity 
primarily due to indiscriminate drug distribution and consequent collateral damage to 
normal cells. Therefore, the cancer treatment requires the combination with pharmaceutical 
science, cell biology, chemistry, electronics, materials, science and technology to improve the 
cancer therapy development. The results of genome sequencing and studies of biological–
genetic function (functional genomics) are combined with chemical, microelectronic and 
micro system technologies to produce medical devices, known as diagnostic ‘Biochips’. The 
multitude of biologically active molecules is expanded by additional novel structures 
created with newly arranged ‘gene clusters’ and (bio-) catalytic chemical processes. With the 
nanotechnology involving the ability to arrange molecules and atoms into molecular 
structures, the drug development in cancer treatment is also limitted. The application of 
micro-machining techniques is growing rapidly and has applications in microfluidics (for 
labs-on-a-chip), in sensors as well as in fiber optics and displays. Nowsaday, direct-write 
technologies are of increasing importance in materials processing. Building the structures 
are made directly without the use of masks, allowing rapid prototyping. The techniques 
comprise plasma spray, laser particle guidance, matrix-assisted pulsed-laser evaporation, 
laser chemical vapor deposition, micro-pen, ink jet, e-beam, focused ion beam and several 
droplet micro-dispensing methods. Micrometer-scale patterns of viable cells are required for 
the next generation of tissue engineering, fabrication of cell-based microfluidicbiosensor 
arrays, and selective separation and culturing of microorganisms. The patterns of viable 
Escherichia coli bacteria have been transferred onto various substrates with laser-based 
forward transfer technique. These tools can be used to create three-dimensional 
mesoscopically engineered structures of living cells, proteins, DNA strands and antibodies 
and two co- fabricate electronic devices on the same substrate to generate cell-based 
biosensors and bioelectronic interfaces and implants. Discrete nanoparticles with controlled 
chemical composition and size distribution are readily synthesized using reverse micelles 
and microemulsions as confined reaction media, but their assembly into well-defined 
superstructures amenable to practical use remains a difficult and demanding task. This 
usually requires the initial synthesis of spherical nanoparticles, followed by further 
processing such as solvent evaporation, molecular crosslinking or template patterning. The 
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interfacial activity of reverse micelles and microemulsions can be exploited to couple 
nanoparticle synthesis and self-assembly over a range of length scales to produce materials 
with complex organization arising from the interdigitation of surfactant molecules attached 
to specific nanoparticle crystal faces. The construction and the evolutionary improvement of 
micro- and nanodevices may be carried out using evolving populations of artificial 
creatures. The biological life is in the control of its own means of reproduction, which 
generally involves in the complex, auto-catalyzing chemical reactions. However, this 
autonomy of the design and manufacture has not yet been realized artificially. Therefore, 
the requirements for cancer treatment are essential and developed rapidly with the 
involvement in numerous physical and chemical methodologies.  
Gene therapy and tissue engineering are new concepts in the treatment of cancer disease. 
The oligonucleotides used in gene therapy with the potential to alter cell function for an 
extended period of time in relation to more established therapeutic agents. Tissue 
engineering aims to regrow tissue structure lost as a result of trauma or cancer through the 
application of engineered materials. Both fields can demonstrate initial success, such as the 
replacement of adenosine deaminase genes in children with severe immunodeficiency and 
the use of synthetic materials to accelerate healing of burns and skin ulcers. Major 
limitations are the low level of expression in gene therapy and the tissue engineers have not 
yet learned to reproduce complex architecture, such as vascular networks, which are 
essential for normal tissue function. A combination of both methods has been used as a new 
strategy to overcome problems remaining. DNA delivery has been described in situ from 
polymer coatings, microspheres and synthetic matrices. DNA material hybrid systems 
promise to enable forms of gene therapy not possible with other gene delivery systems, e.g., 
polymeric microspheres facilitate the expression of orally administered genes.  
Besides, an F1-ATPase biomolecular motor and fabricated nanopropellers was constructed. 
The molecular dynamics of the F1-ATPase at the molecular level were described and the 
suitability of biomolecular devices as nanomolecular machines comprehensively reviewed. 
This chapter aims to present an integrated view of the developments on the discovery of 
new therapy for cancer disease.  
The chapter will drive why cell division gene from bacteria may play a role in drug delivery 
to treat the cancer diseases. The topics will deal with the affects of hyaluronan in cell 
morphology of Lactobacillus acidophilus in minicell producing study and the role of the cell 
division gene from bacteria in minicell production for therapy. In order to study the minicell 
production from bacteria, the function of cell division genes in bacteria as well as minicells 
in cancer treatment. The role of min gene from Streptomyces lavendulae in minicell formation 
for therapy will be studied as the first contribution to cancer therapy.  
2. Minicell production for therapy 
Up to now, the major factor limiting cancer chemotherapeutics is toxicity to the host cells. 
The efforts to the develop the targeted drug delivery systems as nanoparticles, polymer 
therapeutics to cancer cell via cell-surface receptors are also not perfect in leakage in vivo or 
production scale up. Remarkably, bacterial minicells are anucleate nanoparticles produced 
as a result of inactivating the genes controlling the normal bacterial cell division (de Boer et 
al., 1989) due to depressing the polar sites of cell division, may provide the better way for 
cytotoxic drug delivery. The minicells are also prepared from genetically defined minCED(-) 
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chromosomal deletion bacteria and then the subsequent minicells were purified. The   
deletion of minCED(-) out of the bacteria cell may affect on their growth under their control 
so far. Therefore, to find out many methods in the minicell formation without the above 
mentioned discussion is essential. This chapter will point the difficulties in minicell 
production in the hyaluronic acid combination and then suggest the role of minicell 
production in drug resistance that may be the better way for cancer treatment. 
2.1 Affects of hyaluronic acid in cell morphology in Lactobacillus acidophilus 
In order to study the role of minicell formation, this chapter had also used probiotic named 
Lactobacillus acidphilus having a positive impact to the host by helping balance the intestinal 
flora. Relying on the benefit properties of Lactobacillus acidphilus, the new application of this 
probiotic in minicell formation is discussed in this chapter.  
 
 
Fig. 1. The gram stainning of  L. acidophilus with different HA concentration A: 0% ; B: 0.02%; 
C: 0.03% ; D: 0.05%; E: 0.08% ; F: 0.1%. The arrows showed the shape differentiation in 
medium with different concentration of hyaluronic acid. 
The hypothesis was to apply a polymer named hyaluronic acid (HA) commonly used in 
foods, cosmetics, pharmaceutical field to form minicell. Besides, HA was also used to study 
in drug delivery. The delivery system prepared from Lactobacillus acidophilus and probiotic 
was thought to prevent many side effects in cancer treatment. Lactobacillus acidophilus was 
used and maintained in MRS agar and MRS broth. The incubation was performed at 25 – 
30oC in anaerobic condition for 3-4 days. The HA was added into the MRS broth in 5 tubes 
to obtain the final concentrations as 0, 0.03%, 0.05%, 0.08% and 0.1%, respectively. 
Lactobacillus acidophilus in medium with 0.03%, 0.05% of HA was shorter than in the medium 
without HA (Fig.1C).  
A B C 
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Fig. 2. L. acidophilus with HA concentration at A: 0%; B: 0.03%; C: 0.08%; D: 0.1% with the 
zoom out of 1.300 times of scanning electron microscope. Photographs of scanning electron 
microscope with the scale bar is 10µm. 
The cell was shortest in the medium with 0.03% HA and become longer in the medium with 
0.08% and 0.1% than in the medium without HA (Fig.1E and F). To confirm the 
morpholgical differentiation of L. acidophilus with HA, the scanning electron microscope was 
used to observe the cells and the results were showed (Fig.2 A, B, C, D). 
The differentiation of cell caused by HA depends on the different HA concentration . This 
results showed that the minicell phenotype produced by HA were the simple way. Maybe  
HA participate in the gene expression in Lactobacillus acidophilus that will be studied so far. 
Therefore, looking for the new tools to form minicell is neccesary. The chapter suggested the 
way to produce minicell obviously for healthcare. 
 
F 
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2.2 Cell division gene from bacteria in minicell production for therapy 
2.2.1 Min gene in cell division function 
In E. coli, a number of proteins involved in cell division were identified by Hirota and co-
workers who isolated thermo-sensitive mutants that failed to divide at elevated 
temperatures (Hirota et al., 1968). Since these mutants form long filaments, fts (filamentous 
temperature sensitive) was designated. Additional cell division proteins have been 
identified.  For example, 10 proteins such as FtsZ, A, K, Q, L, B, W, I, N and ZipA, which are 
required for cell division, are known until now (Addinall & Holland, 2002; Buddelmeijer & 
Beckwith, 2002; Errington et al., 2003; Margolin, 2000; Rothfield et al., 1999). These 10 
proteins assemble at the site of division into a multi-protein complex called the septal ring. 
Formation of this complex is thought to initiate with the assembly of FtsZ into a ring-like 
structure, the Z-ring, which requires the activity of at least one of the two essential FtsZ 
binding proteins, ZipA or FtsA (Pichoff & Lutkenhaus, 2002). Following addition of both 
ZipA and FtsA to the Z-ring, the remaining division proteins are recruited to mature the 
septal ring (Addinall & Holland, 2002; Buddelmeijer and Beckwith, 2002; Errington et al., 
2003; Hale & de Boer, 2002; Mangolin, 2000; Pichoff & Lutkenhaus, 2002; Rothfield et al., 
1999). After the assembly is completed, the proteins for the formation of the septal ring 
function in concert to mediate the coordinated invagination of three cell envelope layers 
such as the inner membrane, the peptidoglycan layer, and the outer membrane. 
Unfortunately, very little is known about the roles of many of the division proteins in this 
process. Spatital regulation of Z-ring assembly by the Min system is independent of 
nucleoid occlusion, which is evident in anucleate cells produced by chromosome 
segregation mutants. In the cells, the Z-rings assemble at or near mid-cell, suggesting that 
the Min system alone is sufficient to regulate the proper placement of the Z-ring (Sun et al., 
1998). In contrast, in cells lacking a functional Min system, nucleoid occlusion is not 
sufficient to direct Z-ring assembly, and the division occurs consequently at any one of the 
three potential division sites dictated by the nucleoid occlusion. If the cell division occurs at 
a polar potential division site, a chromosomeless-minicell and a multinucleate filament are 
produced (Adler et al., 1967; de Boer et al., 1989). The first minicell mutant in E. coli has been 
isolated in 1967 (Adler et al., 1967). The mutations responsible for the minicell phenotype 
were mapped to the minB locus (Adler et al., 1967), which was later cloned and 
characterized (de Boer et al., 1989). The minB locus encodes three proteins, designated MinC, 
MinD, and MinE, all of which are required for proper the Min system function. In B. subtilis, 
the Min system includes MinC, MinD and DivIVA. 
2.2.2 MinC 
MinC comprised of two domains of roughly equal size (de Boer et al., 1989; Hu &  
Lutkemhaus, 2001). The N-terminal domain interacts with FtsZ and is required and 
sufficient to inhibit FtsZ polymerization in vitro and Z-ring formation in vivo (Hu & 
Lutkenhaus, 2003). The mechanistic basis of this inhibition is unknown. The C-terminal 
domain is required for homodimerization of the protein and for interaction with activators 
of Min function, MinD and DicB (Hu & Lutkenhaus, 2003; Johnson et al., 2002; Szeto et al., 
2001b). The DicB protein is encoded on the cryptic prophage Kim, and under normal 
conditions, expression of DicB is actively repressed (Cam et al., 1988). In the absence of these 
activators, MinC blocks cell division only when present at a level at least 25-fold greater 
than normal. In the presence of either activator, physiological levels of MinC are sufficient to 
inhibit division (de Boer et al., 1990; 1992b). 
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2.2.3 MinD 
MinD is a part of the ParA superfamily of ATPase and is the most highly conserved of the 
Min proteins (Szeto et al., 2003). It generally associates with the inner membrane and is 
required for the binding and activation of MinC (Zhou et al., 2004). It contains five distinct 
domains. Three of which (P-loop, Switch I and Switch II) are thought to be important for ATP-
binding (Gérard et al., 1998). The P-loop and switch II sites are deviant Walker A and B-type 
ATP binding motifs. Mutations in the P-loop, Switch I and Switch II domains are effective to 
ATP-binding causing the mislocalization of MinD and a concurrent mislocalization of MinC 
(Karoui et al., 2001). This suggests that ATP-binding is essential for membrane binding and 
activation of MinC. The ATPase domain is also required for an appropriate MinE-dependent 
localization to the cell poles (Maston et al., 1999b). Mutations in the ATPase domain of B. 
subtilis MinD are no longer restricted to the cell poles (Karoui et al., 2001). Instead, they diffuse 
throughout the inner membrane, suggesting a loss of interaction with DivIVA. However, 
MinD can localize to the division sites, in the presence or absence of DivIVA (Lee & Price, 
1993). Mutations of the Switch I and Switch II in E. coli disrupt MinC activation, but not MinD 
localization (Zhou et al., 2004). Initial attempts for B. subtilis MinD with GFP (green 
fluorescence protein) at the C-terminal end have suggested that the protein does not function 
(Marston et al., 1998). Sequence analysis revealed a conserved C-terminal amphipathic helix 
(Hu et al., 2003; Szeto et al., 2002), that was likely disrupted by the addition of GFP. Even 
though structure prediction algorithms and the crystal structure failed to predict any 
membrane or membrane binding domains (Hayashi et al., 2001), deletion analysis has shown 
that the last 10 amino acids are required for membrane binding in E. coli (Zhou et al., 2003). B. 
subtilis also contains a C-terminal amphipathic helix required for membrane binding (Szeto et 
al., 2002). Truncations or mutations in this region disrupt MinD’s ability to bind the 
membrane. Mutations that allow MinC activation but disrupt DivIVA interaction have also 
been identified (Karoui et al., 2001). E. coli MinD binds the membrane in an ATP-dependent 
manner in vitro (Lackner et al., 2003). MinD will associates with the phospholipids vesicles in 
the presence of ATP and Mg2+, while the ADP-bound form will not. MinE stimulates the 
ATPase activity of MinD to release it from the membrane. Substitution with non hydrolysable 
forms of ATP cause MinD to remain associated with the membrane even in the presence of 
MinE. The ability of MinE to release MinD, and thus MinC, from the membrane is thought to 
be the driving force behind the oscillations in E. coli (Howard et al., 2001). 
2.2.4 MinE 
MinE is an 88 amino acid protein with two known functional domains. The N-terminal 
domain ( DMinE, amino acids 1-33) is required and sufficient to interact with MinD and to 
counteract MinCD-mediated division inhibition (Huang et al., 1996). The C-terminal 
topological specificity domain (TSMinE, amino acids 34-88) is required to suppress the 
inhibitory activities of MinCD specifically at mid-cell. Additionally, this domain mediates 
homodimerization of the protein (King et al., 1999; 2000; Pichoff et al., 2002). The structure of 
the C-terminal domain has been solved (King et al., 2000), revealing that the protein 
dimerizes in an anti-parallel fashion. The N-terminal domain is not shown in the structure, 
but is predicted to be a nascent helix (King et al., 1999). 
2.2.5 DivIVA 
A major difference between E. coli and B. subtilis is that B. subtilis uses DivIVA to sequester 
MinCD to the cell poles. Unlike the MinCD oscillations caused by MinE in E. coli, the 
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localization of B. subtilis MinCD is static (Edwards et al., 1997). Furthermore, E. coli does not 
contain a DivIVA homologue, nor does B. subtilis have a MinE homologue (Lee & Price, 
1993). DivIVA in B. subtilis is a 19.5 kDa protein, but soluble DivIVA exists as a 145 kDa 
oligomer in vivo (Muchova et al., 2002). The structure of membrane associated DivVIA 
(~40%) remains unknown. Transmissible electron microscope images of DivIVA 
(Glu162Lys), a functional point mutant, reveals a ‘doggy-bone’ like structure capable of 
further assembly into two dimensional structures (Stahler et al., 2004). DivIVA localizes to 
the poles and midcell division sites, sometime, during the assembly of the cell division 
machinery. The timing and mechanism of localization is still unclear. After division, DivIVA 
remaining at the division sites is not essential, however. DivIVA must then have some 
function beyond that of localizing MinCD. DivIVASC from the S. coelicolor, which is 
homologues to DivIVA from Bacillus subtilis, is essential and directly involved in hyphal tip 
growth and morphogenesis. A DivIVASC-EGFP hybrid was distinctively localized to hyphal 
tips and lateral branches. DivIVASC is a novel bacterial morphogenesis, and it is closely 
localized at the apical sites of peptidoglycan assembly in Streptomyces hyphae. 
2.2.6 Min system dynamics regulate the activity of MinC 
The cell division is determined by the cellular distribution of MinC, which is regulated by 
both MinD and MinE. In addition, MinD and MinE influence the other cellular distribution. 
MinD, MinC and MinE are cytoplasmic, and MinC is unable to efficiently inhabit Z-ring 
assembly (Hu & Lutkenhaus, 2001). As a result, cells show a minicelling division phenotype 
(Min cells), where the cells frequently divide close to either cell pole (de Boer et al., 1989). In 
MinE cells, MinC and MinD are assembled along the entire membrane. This static, uniform 
distribution of MinC blocks the Z-ring assembly at all sites, resulting in the formation of 
long, non-septate filamentous cell (Sep-cells) (de Boer et al., 1989; Hu & Lutkenhaus, 2001; 
Rowland et al., 2000). In cells expressing three Min proteins (MinC, D and E), a wild-type 
scenario, MinC undergoes a rapid and dynamic localization cycle in which the protein 
oscillates from one cell pole to other every 20-30 seconds (Hu and Lutkenhaus, 2001). As the 
result of this pole-to-pole oscillation, the time-averaged concentration of the division 
inhibitor is greatest as the cell poles and lowest at mid-cell, and this concentration 
differential is proposed to direct Z-ring assembly to mid-cell (Hale et al., 2001; Howard et 
al., 2001; Huang et al., 2003; Kruse, 2002; Meinhardt and de Boer, 2001). This dynamic 
distribution of MinC is driven by MinD and MinE, which themselves undergo a coupled 
oscillatory localization cycle (Hale et al., 2001, Shih et al., 2002). At the start of this cycle, 
MinD and a portion of MinE assemble on the membrane along one half of the cell in a 
pattern resembling a test tube (MinD/E tube), while another portion of MinE assembles at 
the rim of this tube forming a ring (E-ring). The MinD/E tube undergoes a continuous cycle 
of disassembly from the membrane at one cell end and concurrent reassembly on the 
membrane at the opposite cell end. The E-ring closely follows the location of the MinD/E 
tube, always appearing to be associated with its rim. MinC plays no role in the mechanism 
of oscillation, and the cellular location of MinC follows that of MinD (Hale et al., 2001; 
Rowland et al., 2000). While the MinD/E tube and E-ring do not appear to have an 
underlying structure in live cells analyzed by conventional 2-dimensional fluorescence 
microscopy, spiral-like accumulations of the proteins in what would represent the MinD/E 
tube and E-ring have been observed in fixed cells analyzed by 3-dimensional deconvolution 
microscopy. This observation suggests that the bulk of Min protein dynamics occurs along 
spiral tracks within the cell (Shih et al., 2003). 
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2.2.7 MinCD during sporulation 
Deletions in the MinCD locus cause a decrease in sporulation of nearly ten fold (Barak et al., 
1998) although the relative sporulation efficiency is nearly identical to wild-type. The cause 
of the decrease is unclear as MinCD’s role in sporulation has not been well examined. B. 
subtilis with null mutations in MinCD form thin, sporulation like septa at the midcell, 
suggesting that MinCD is helpful to inhibit sporulation septa from forming at the midcell. 
Since its role during vegetative growth is to prevent FtsZ ring formation at the poles, 
MinCD may also trigger the switch from midcell division to polar division in conjunction 
with spo0A. It’s also been suggested that MinCD confers polarity to SpoIIIE dependent 
chromosome translocation by inhibiting the assembly of forespore expressed SpoIIIE (Sharp 
et al., 2002). In the absence of MinCD, SpoIIIE can assemble on the forespore side of the 
septum and can reverse translocate DNA into the mother cell leading to anucleate 
forespores. 
2.2.8 Conservation of Min proteins 
MinD is well conserved among many bacteria and archaea and is also found in number of 
eukaryotic chloroplasts (Gérard et al., 1998). Interestingly, this high degree of conservation 
is not shared with MinC and/or MinE suggesting that the mechanism by which MinD 
homologues lack MinC and/or MinE regulates division site placement is not conserved in 
all organisms (Margolin, 2000; Rothfield et al., 1999). For example, B. subtilis has both MinC 
and MinD but lacks MinE. In B. subtilis, DivIVA imparts topological specificity to MinCD-
mediated division inhibition in a manner very different from that of MinE (Cha & Stewart, 
1997). DivIVA, which stably associates with cell poles, recruits MinCD to the poles and 
thereby, spatially restricts the inhibitory activity of the complex to the polar potential 
division sites (Marston & Errington, 1999b; Marston et al., 1998). Therefore, the Min protein 
oscillation is not required to spatially regulate the Z-ring assembly in all organisms. 
2.2.9 Minicells in cancer treatment  
Molecularly targeted drugs such as cell cycle inhibitors are being developed to achieve a 
higher degree of tumor cell specificity and reduce toxic side effects. Unfortunately, relative 
to the cytotoxics, many of the molecularly targeted drugs are less potent and the target 
protein is expressed only at certain stages of the cell cycle thus necessitating regimens like 
continuous infusion therapy to arrest a significant number of tumor cells in a heterogeneous 
tumor mass (Jennifer et al., 2007). Therefore, trend to produce minicells or nanocells from 
non-pathogen bacteria is essential. The minicells were made from bacteria and contained 
pieces of genetic material, known as short interference RNA (siRNA), which knockout or 
''silence'' the drug-resistant genes of tumours. Bacterial membranes might be quite different 
because they have protein channels (in their membrane) through which siRNAs can enter 
(Jennifer et al., 2009). By means of the receptors in the tumor surface, the minicell will 
specify and deliver the drugs to the tumors. Minicells are produce by minicell producing 
parent cells. These parent cells undergo cell division in an abnormal manner that produces a 
chromosomal-containing cell and a minicell lacking a copy of the parental chromosome. 
Minicells are often smaller than their parent cells. For example, minicells produced from E. 
coli are generally spherical in shape and are about 0.1 to about 0.3 m, whereas whole E. coli 
cells are about 2 to about 10m in length. The minicell can be tagged with siRNA that is also 
play a role in disease prevention and drug resistant reduce. It was discovered that an 
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unprecedented concentration of one million to ten million drug molecules can be packaged 
within a minicell. In contrast, other nanovectors such as liposomes have been shown to 
package ~10,000 molecules of drug within each liposome. Similarly, armed antibodies can 
conjugate only four to ten drug molecules per antibody. The potency of observed anti-tumor 
effects may depend on the concentration of a drug that is delivered intracellularly within 
cancer cells. At present, the cancer treatment is the big pressure in the world because of the 
high cost for treatment such as the high price of monoclonal antibodies. This is the 
difficulties of the pharmaceutical companies which did not supply enough demands wheras 
minicell will made the cost reduce and delivers the small amounts of many drugs 
intracellularly and then decrease the drug resistance of the cell (Jennifer et al., 2007). To get 
improvement of minicells, the research of min gene encoding for cell division will be done to 
understand about the new approach for drug treatment. The min gene was cloned and 
studied for the function. The generated minicells or nanocells during gene expression will 
be used to study as the drug delivery to cancer cell.  
2.2.10 Role of min gene from Streptomyces lavendulae in minicell formation for 
therapy  
There are many cell division genes in bacteria summarized as above. However, only one 
minD gene exists in the human chromosome. To understand the role of minicell in drug 
delivery in human, the study tried to find the diversity of minD gene in the bacteria which 
have the linear structure as human chromosome that belong to Streptomyces. Streptomyces 
have a complex morphological differentiation and are well-known for their ability to 
produce an enormous variety of bioactive secondary metabolites, such as antibiotics and 
immunosuppressant drugs (Wright et al., 1976b).The minD gene Streptomyces coelicolor and 
Streptomyces avernitilis genome have been sequenced completely (Ikeda et al., 2003; Betley et 
al., 2002). In Streptomyces, there are minD1, minD2 or minD3 depending on the these strains. 
Clearly, the min gene cluster has also tried to obtain in  Streptomyces lavendulae. Because 
Streptomyces coelicolor and Streptomyces avernitilis are well studied, the aim of the minD gene 
study focused on Streptomyces lavendulae. The cloned min gene was expressed in many way 
to analyze the functional regulations of cell division. The goal is to develop the effects of 
Min homolog harbored by Streptomyces in morphological change, especially the minicell and 
filamentous morphology in Escherichia coli. The minicells generated by min gene expression 
gave many hopes for cancer- targeted drug delivery in cancer therapy while the 
chemotherapeutic therapy used nowadays are not specific but also toxic to cancer cell.  
The introduction of min gene with the sequence containing 49 nucleotides at upstream of 
min gene gave the apparent morphological alteration into minicells when using the pET 
28a(+) as expression vector while the introduction of min gene gave the filamentous under 
the pET 21a(+). To construct E. coli expressing the S. lavendulae min gene, a PCR with 
primers as 5’- CACCATATGACCACTCGAATCCTCCCCGC- 3’ and 5’- CACCTCGAGGCC 
CTCCCGGCCGCGC- 3’ was performed. The product was treated with NdeI and XhoI (italic 
sites), and inserted into pET 21a(+) to create pET 21a(+)/min. To amplify upregulated-min 
gene (min containing 49-bp upstream of min), PCR primers (5’-
GGAATTCCAGTCCCACCGACCGCACGTAC-3’and 5’-CCGCTCGAGCGGGCCACGAGC 
AGCAGGATC-3) were designed. The resulting amplified product was digested with EcoRI 
and XhoI (italic sites) and inserted into pET 28a(+) to create pET 28a(+)/upregulated-
minDSL.  
www.intechopen.com
 Advances in Cancer Therapy 
 
92
Transformation the constructed plasmids in E. coli were performed. E. coli BL21(DE3) 
harboring pET 21a(+)/min and pET 28a(+)/upregulated-min was grown at 37°C in 1L of an 
LB medium to OD600=0.5, whereupon isopropyl-D-thiogalacto-pyranoside (IPTG) was 
added to culture at the final concentration of 0.5 mM to induce the expression of Min. The E. 
coli cells were grown for 5.5 h at 28°C and observed by microscope. Introduction of pET 
21a(+)/min into E. coli BL21(DE3) cell caused a filamentous shape, as observed by a light 
microscope (Fig. 3B) and scanning electron microscope (Fig. 3D). The investigation of 
 
  
A B 
  
C D 
Fig. 3. The cell shapes of E. coli BL21 (DE3) carrying min gene when using pET 21a(+) as an 
expression vector. (A) and (B) are the pictures filmed by light microscope, but (C) and (D) 
are the picture filmed by scanning electron microscope. E. coli BL21 (DE3) transformed with 
pET 21a(+) is a typical rod shape, as shown in (A) and (C). The same host transformed with 
pET 21a(+)/min exhibits a filamentous phenotype, as shown in (B) and (D). Red arrows 
show the indentations along the cells.Photographs of light microscope with the scale bar is 5 
m, and both figures are at the same magnification. Photographs of scanning electron 
microscope with the scale bar is 1 m. 
minicell production indicates that the production of minicells is blocked when maltose was 
added in the culture. By the microscopic analysis, the indentations in the cell wall of E. coli 
reflect the min gene may be play a role in cellular mechanism. The relationship between 
phenotype differentiation and drug resistance was not clear. However, in the E. coli system 
with the overexpression of MinCDE, the function of min gene from Streptomyces  was 
activated by means of the putative primary promoter upstream of min gene along with the 
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selective conditions of environment. The interaction between Min proteins in E. coli  in the 
different cultured conditions maybe also affected on the cells. This hypothesis should be 
studied before the minicells formed by this way will be applied in treatment. 
To facilitate further study the function of Min protein, the E. coli BL21(DE3) carrying the pET 
28a(+)/upregulated-min gene carrying plasmid was overexpressed. Under the presence of 
IPTG, the transformant took a minicell phenotype (Fig. 4B), whereas the same cell 
transformed with pET 28a(+) exhibited a normal rod-shaped morphology (Fig. 4A). The 
minicells are produced by a process that is similar to the normal cell division except that it 
occurs near one or both poles of the cell. The division process, that generates the minicells,  
 
  
A B 
  
C D 
 
Fig. 4. The cell shapes of E. coli BL21 (DE3) carrying min gene when using pET 28a(+) as an 
expression vector.(A) E.coli BL21(DE3) cells were transformed with pET 28a(+). (B) E. coli 
BL21(DE3) cells were transformed pET 28a(+)/upregulated-min. (C) Phenotype of E.coli 
BL21 (DE3) cells were transformed with pET 28a(+) in LB medium supplemented with 
maltose (1%). (D) E. coli BL21(DE3) cells were transformed pET 28a(+)/ upregulated-min in 
LB medium supplemented with maltose (1%). Photographs of light microscope with the 
scale bar is 5m, and both figures are at the same magnification.  
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seems to be “normal” in many ways. In this case, DNA is not distributed to both sides of the 
division plane. The production of minicells is a consequence of the unusual genetic 
constitution and does not require any unusual manipulation of the environment. They has 
anticipated that the minicell phenotype will be valuable in a variety of genetic and 
biochemical studies. During morphological change in bacteria, the Min expression caused 
different solubility (Nguyen et al., 2008; Nguyen, 2010). Because the morphological change, 
the physiological differentiation concerning to drug resistant may also be effected. That is 
the why min gene is essential for cell division and viability in E. coli.  The E. coli BL21(DE3) 
carrying the pET 28a(+)/upregulated-min carrying plasmid was overexpressed under the 
presence of maltose, the cell are longer than the E. coli BL21(DE3) carrying the pET 28a(+) 
(Fig. 4C, D). In a conclusion, the overexpression of S. lavendulae minDSL in E. coli causes the 
cellular shape change. That is the consequence of the min gene in fused construction that 
results in the filamentous shape, whereas the native Min corrects the minicell phenotype in 
E. coli (Fig. 4B). Since the minicell phenotype will be valuable in a variety of genetic and 
biochemical studies, a native Min protein was purified. After E. coli BL21 (DE3) carrying min 
was grown, the cell mass was collected in the inclusion body from the cell-free extract. 
Washing the inclusion body with 1% n-decyl-D-glucopyranoside was useful to reduce the 
contaminated proteins. The washed inclusion body was dissolved in a buffer containing 1% 
n-decyl-D-maltopyranoside. The Min protein was purified from the inclusion body, as 
described in the experimental procedures section. The Min protein was purified to 
homogeneity, as shown in Fig. 5. This procedure showed the difference of the native Min 
protein properties from the tagged one. The experiment pointed out the morphological 
differentiation as well as the different expressing ways caused by min gene. Probably the 
min gene of Streptomyces had any effects on Escherichia coli. The result supported that the 
application of minicells obtained by this procedure should be studied well before used as 
drug delivery. 
 
 
Fig. 5. Purification of Min protein was analyzed by Tricine-SDS-PAGE. The arrow showed 
the purified 46 kDa of Min protein after it was dissolved in a buffer containing 1% n-decyl-
D-maltopyranoside.   
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Because there were the shape changes in E. coli transformed by these constructions as pET 
21a(+), pET 28a(+), pET 21a(+)/ min, pET 28a(+)/upregulated-min, the drug resistance assay 
of minicells was also performed curiously. Interestingly, there was also drug resistance. The 
test was measured the turbidity after the E. coli were cultured with D-cycloserine at the 
interval time. To investigate the role of min gene  in antibiotic resistance, the D-cycloserine 
resistant assay was performed. The results were in fig. 6. Remarkably, the resistance in 
minicells carrying pET 28a(+)/upregulated-min was the highest than the filament cells pET 
21a(+)/ min and other controls. As the result, the minicell formation will give a mission in 
drug delivery and drug resistance in tuberculosis but in cancer diseases. More studies will 
be done so far to explain the mechanisms and to give more design for drug delivery in 
cancer therapy. 
 
Fig. 6. D-cycloserine resistance assay in E. coli. the resistance in minicells carrying pET 
28a(+)/upregulated-min was the highest than the filament cells pET 21a(+)/ min and the  
controls. 
3. Conclusion 
The phenotype differentiation and drug resistance in Escherichia coli were not clear. 
However, by the microscopic analysis, the indentations in the cell wall reflect that min may 
play a role in cellular mechanism. Our experiment suggests the considerations that bacterial 
shapes are not accidental but are biologically important. In the E. coli system with the 
overexpression of MinCDE, the function of Min protein from S. lavendulae was activated by 
means of the putative primary promoter upstream of min gene along with the selective 
conditions of environment. The chapter showed the effects of min gene of Streptomyces in E. 
coli in the formation of minicell phenotype which may participate in drug resistance that is 
interested in cancer treatment and vaccine preparation. The minicells produced by the 
expression of min gene with the upstream gave the high resistance of D-cycloserine, an 
antibiotic for tuberculosis treatment. This chapter provided the benefit of bacterial minicells 
which play in drug delivery and resistant to the drug used in cancer treatment. In the other 
hands, the min gene in human containing F1-ATPase is also similar to min genes bacteria. 
The purified Min protein (Fig. 5) showed the activity of an ATPase (data not shown). The 
Growth of cell 
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molecular dynamics of the F1-ATPase at the molecular level will be studied to develop the 
biomolecular devices as nanomolecular machines for therapy. 
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